Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Feb 8, 2016
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Award
Common Stock
2016-02-04+22,600→ 264,055 total - Award
Stock Option (Right to Buy)
2016-02-04+63,500→ 63,500 totalExercise: $38.11Exp: 2026-02-04→ Common Stock (63,500 underlying)
Footnotes (2)
- [F1]Restricted stock awards vest in four equal annual installments beginning February 4, 2017.
- [F2]The stock options vest in four equal annual installments beginning February 4, 2017.